Steris (STE) Short-Term Debt issuances (2018 - 2026)
Steris' (STE) quarterly Short-Term Debt issuances came in at $37.8 million in Q1 2026, up 129.69% year-on-year from $16.5 million in Q1 2025, and up 979.07% quarter-over-quarter from -$4.3 million in Q3 2025.
Steris (STE) Short-Term Debt issuances (2018 - 2026) Analysis & Trends
Steris' Short-Term Debt issuances history runs 9 years deep, the most recent figure standing at $37.8 million for Q1 2026.
- On a quarterly basis, Short-Term Debt issuances rose 129.69% year-over-year to $37.8 million in Q1 2026; TTM through Mar 2026 was $3.0 million, a 100.67% increase from a year earlier, with the FY2026 full-year figure at $3.0 million, up 100.67% from the prior year.
- Short-Term Debt issuances climbed to $37.8 million in Q1 2026 per STE's latest filing, from -$4.3 million in the prior quarter.
- Across five years, Short-Term Debt issuances topped out at $535.7 million in Q3 2023 and bottomed at -$253.2 million in Q2 2024.
- The 5-year median for Short-Term Debt issuances is $4.7 million (2022), against an average of -$407000.0.
- Biggest YoY gain for Short-Term Debt issuances was 762.6% in 2023; the steepest drop was 490.83% in 2023.
- Year by year, Short-Term Debt issuances stood at $117.4 million in 2022, then tumbled by 206.87% to -$125.5 million in 2023, then jumped by 120.63% to $25.9 million in 2024, then sank by 116.6% to -$4.3 million in 2025, then soared by 979.07% to $37.8 million in 2026.
- Per Business Quant, the three latest STE Short-Term Debt issuances figures stand at $37.8 million (Q1 2026), -$4.3 million (Q3 2025), and -$30.5 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 31.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -164.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 259.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 12.88 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -1.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 37.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.80 Mn |
| Mar 31, 2026 | 37.80 Mn |
| Sep 30, 2025 | -4.30 Mn |
| Sep 30, 2025 | -4.30 Mn |
| Jun 30, 2025 | -30.50 Mn |
| Jun 30, 2025 | -30.50 Mn |
| Mar 31, 2025 | -127.30 Mn |
| Mar 31, 2025 | -127.30 Mn |
| Dec 31, 2024 | 25.90 Mn |
| Dec 31, 2024 | 25.90 Mn |
| Sep 30, 2024 | -91.70 Mn |
| Sep 30, 2024 | -91.70 Mn |
| Jun 30, 2024 | -253.20 Mn |
| Jun 30, 2024 | -253.20 Mn |
| Mar 31, 2024 | -84.00 Mn |
| Mar 31, 2024 | -84.00 Mn |
| Dec 31, 2023 | -125.52 Mn |
| Dec 31, 2023 | -125.52 Mn |
| Sep 30, 2023 | 535.67 Mn |
| Sep 30, 2023 | 535.67 Mn |